Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessia Ciarrocchi

Showing results (21-30 of 122) with videos related to

Pageof 13
Sort By:
International Journal of Endocrinology|September 13, 2014
Update on anaplastic thyroid carcinoma: morphological, molecular, and genetic features of the most aggressive thyroid cancerMoira Ragazzi, Alessia Ciarrocchi, Valentina Sancisi, et al.
European Journal of Endocrinology|January 14, 2015
TERT promoter mutations are associated with distant metastases in papillary thyroid carcinomaGreta Gandolfi, Moira Ragazzi, Andrea Frasoldati, et al.
Molecular Cancer Research : MCR|February 6, 2021
Long Noncoding RNA <i>NEAT1</i> Acts as a Molecular Switch for BRD4 Transcriptional Activity and Mediates Repression of BRD4/WDR5 Target GenesMariaelena Pistoni, Teresa Rossi, Benedetta Donati, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 10, 2019
HDACs control RUNX2 expression in cancer cells through redundant and cell context-dependent mechanismsGloria Manzotti, Federica Torricelli, Benedetta Donati, et al.
Cell Death Discovery|March 20, 2026
The dual impact of GBA1 in disease: from germline mutations in neurological disorders to alterations in cancerValentina Fantini, Giulia Di Rauso, Valentina Fioravanti, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 18, 2007
Id1 restrains myeloid commitment, maintaining the self-renewal capacity of hematopoietic stem cellsVladimir Jankovic, Alessia Ciarrocchi, Piernicola Boccuni, et al.
The Journal of Clinical Endocrinology and Metabolism|March 28, 2013
Allele percentage of the BRAF V600E mutation in papillary thyroid carcinomas and corresponding lymph node metastases: no evidence for a role in tumor progressionGreta Gandolfi, Valentina Sancisi, Federica Torricelli, et al.
Cell Death & Disease|August 31, 2018
The bHLH transcription factor DEC1 promotes thyroid cancer aggressiveness by the interplay with NOTCH1Cristina Gallo, Valentina Fragliasso, Benedetta Donati, et al.
Plos One|September 27, 2013
Cadherin 6 is a new RUNX2 target in TGF-β signalling pathwayValentina Sancisi, Greta Gandolfi, Moira Ragazzi, et al.
Pathology, Research and Practice|February 10, 2015
Lymph node melanocytic nevi: pathogenesis and differential diagnoses, with special reference to p16 reactivitySimonetta Piana, Elena Tagliavini, Moira Ragazzi, et al.
Pageof 13

Showing results (21-30 of 122) with videos related to

Sort By:
Pageof 13
International Journal of Endocrinology|September 13, 2014
Update on anaplastic thyroid carcinoma: morphological, molecular, and genetic features of the most aggressive thyroid cancerMoira Ragazzi, Alessia Ciarrocchi, Valentina Sancisi, et al.
European Journal of Endocrinology|January 14, 2015
TERT promoter mutations are associated with distant metastases in papillary thyroid carcinomaGreta Gandolfi, Moira Ragazzi, Andrea Frasoldati, et al.
Molecular Cancer Research : MCR|February 6, 2021
Long Noncoding RNA <i>NEAT1</i> Acts as a Molecular Switch for BRD4 Transcriptional Activity and Mediates Repression of BRD4/WDR5 Target GenesMariaelena Pistoni, Teresa Rossi, Benedetta Donati, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 10, 2019
HDACs control RUNX2 expression in cancer cells through redundant and cell context-dependent mechanismsGloria Manzotti, Federica Torricelli, Benedetta Donati, et al.
Cell Death Discovery|March 20, 2026
The dual impact of GBA1 in disease: from germline mutations in neurological disorders to alterations in cancerValentina Fantini, Giulia Di Rauso, Valentina Fioravanti, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 18, 2007
Id1 restrains myeloid commitment, maintaining the self-renewal capacity of hematopoietic stem cellsVladimir Jankovic, Alessia Ciarrocchi, Piernicola Boccuni, et al.
The Journal of Clinical Endocrinology and Metabolism|March 28, 2013
Allele percentage of the BRAF V600E mutation in papillary thyroid carcinomas and corresponding lymph node metastases: no evidence for a role in tumor progressionGreta Gandolfi, Valentina Sancisi, Federica Torricelli, et al.
Cell Death & Disease|August 31, 2018
The bHLH transcription factor DEC1 promotes thyroid cancer aggressiveness by the interplay with NOTCH1Cristina Gallo, Valentina Fragliasso, Benedetta Donati, et al.
Plos One|September 27, 2013
Cadherin 6 is a new RUNX2 target in TGF-β signalling pathwayValentina Sancisi, Greta Gandolfi, Moira Ragazzi, et al.
Pathology, Research and Practice|February 10, 2015
Lymph node melanocytic nevi: pathogenesis and differential diagnoses, with special reference to p16 reactivitySimonetta Piana, Elena Tagliavini, Moira Ragazzi, et al.
Pageof 13